AMADABLAM HEALTH LTD.

Company Registration Number:
09880402 (England and Wales)

Unaudited micro entity accounts for the year ended 30 November 2024

Period of accounts

Start date: 01 December 2023

End date: 30 November 2024

AMADABLAM HEALTH LTD.

Contents of the Financial Statements

for the Period Ended 30 November 2024

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

AMADABLAM HEALTH LTD.

Company Information

for the Period Ended 30 November 2024




Registered office: 3
Plainfields Avenue
Brighton
England
BN1 8RJ
Company Registration Number: 09880402 (England and Wales)

AMADABLAM HEALTH LTD.

Balance sheet

As at 30 November 2024


2024
£

2023
£
Current assets: 14,579 29,583
Net current assets (liabilities): 14,579 29,583
Total assets less current liabilities: 14,579 29,583
Creditors: amounts falling due after more than one year: ( 26,192 ) ( 35,300 )
Total net assets (liabilities): ( 11,613 ) ( 5,717 )
Capital and reserves: ( 11,613 ) ( 5,717 )

AMADABLAM HEALTH LTD.

Balance sheet continued

For the year ending 30 November 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 18 November 2025
And Signed On Behalf Of The Board By:

Name: Himalaya Gurung
Status: Director

The notes form part of these financial statements

AMADABLAM HEALTH LTD.

Footnotes to the Financial Statements

for the Period Ended 30 November 2024

  • 1. Employee Information

    Average number of employees: 1

AMADABLAM HEALTH LTD.

Footnotes to the Financial Statements

for the Period Ended 30 November 2024

  • 2. Off balance sheet disclosure

    No